Volatile metabolites of pathogens: a systematic review.
Bos LD, Sterk PJ, Schultz MJ. · 2013
Read Volatile metabolites of pathogens: a systematic review. by Bos LD, Sterk PJ, Schultz MJ. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3649982.txt.
Introduction
Germs can be smelled out, in a sense, Bos, Sterk and Schultz argue in a 2013 systematic review in PLoS Pathogens. Bacteria give off volatile chemicals, gases a body can release in breath, and humans do not make some of them. Fast proof of which germ infects a very ill patient sharpens care. The review gathered work on the six germs that most often drive sepsis, the body's extreme response to infection.
Thirty-one articles made the cut. All six give off four shared chemicals: isopentanol, formaldehyde, methyl mercaptan and trimethylamine. Since humans make none, the four could mark germ presence in breath. Further chemicals marked single germ kinds, among them hydrogen cyanide for one lung germ. Growth stage, food medium and strain shifts were often left uncontrolled, a flaw the authors flag.
Catalog record
| CREATOR | Bos LD, Sterk PJ, Schultz MJ. |
|---|---|
| YEAR | 2013 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Volatile Metabolites of Pathogens: A Systematic Review By Lieuwe D. J. Bos, Peter J. Sterk, Marcus J. Schultz, Chetan E. Chitnis Published in: PLoS Pathogens DOI: 10.1371/journal.ppat.1003311 ABSTRACT Ideally, invading bacteria are detected as early as possible in critically ill patients: the strain of morbific pathogens is identified rapidly, and antimicrobial sensitivity is known well before the start of new antimicrobial therapy. Bacteria have a distinct metabolism, part of which results in the production of bacteria-specific volatile organic compounds (VOCs), which might be used for diagnostic purposes. Volatile metabolites can be investigated directly in exhaled air, allowing for noninvasive monitoring. The aim of this review is to provide an overview of VOCs produced by the six most abundant and pathogenic bacteria in sepsis, including Staphylococcus aureus, Streptococcus pneumoniae, Enterococcus faecalis, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli. Such VOCs could be used as biological markers in the diagnostic approach of critically ill patients. A systematic review of existing literature revealed 31 articles. All six bacteria of interest produce isopentanol, formaldehyde, methyl mercaptan, and trimethylamine. Since humans do not produce these VOCs, they could serve as biological markers for presence of these pathogens. The following volatile biomarkers were found for identification of specific strains: isovaleric acid and 2-methyl-butanal for Staphylococcus aureus; 1-undecene, 2,4-dimethyl-1-heptane, 2-butanone, 4-methyl-quinazoline, hydrogen cyanide, and methyl thiocyanide for Pseudomonas aeruginosa; and methanol, pentanol, ethyl acetate, and indole for Escherichia coli. Notably, several factors that may effect VOC production were not controlled for, including used culture media, bacterial growth phase, and genomic variation within bacterial strains. In conclusion, VOCs produced by bacteria may serve as biological markers for their presence. Goal-targeted studies should be performed to identify potential sets of volatile biological markers and evaluate the diagnostic accuracy of these markers in critically ill patients. INTRODUCTION Sepsis is increasingly prevalent in the developed world, affecting 240 per 100,000 persons per year [1]. Early start of targeted antibiotics lowers mortality [2]. However, in the majority of cases, empirical antibiotic treatment is untargeted due to inadequate diagnostics, resulting in a three-fold increase in mortality when compared to targeted antibiotic treatment [3]. Ideally, invasion of morbific pathogens is detected as early as possible; the strain of the causative pathogens is identified swiftly, and antimicrobial sensitivity is rapidly known, preferably before start of antimicrobial therapy. However, cultures may take days to become positive and have limited sensitivity, especially in patients already receiving antibiotics because of a previous infection [4]. In addition, contamination could lead to false-positive results and therefore may increase prescription of unnecessary antibiotics [5]. Gram-stain results and direct cellular examination (e.g., of bronchoalveolar lavage fluid) are rapidly available but have limited sensitivity and specificity, and neither tell the exact strain of pathogen nor its antimicrobial sensitivity [6], [7]. These disadvantages also apply to several biomarkers (C-reactive protein, procalcitonine, pro-adrenomedullin and endotoxin) 8–10. PCR-based diagnostics are currently under investigation and although the results are promising, PCR takes hours before results are available and is laborious and costly [11]. In ancient times, physicians relied heavily on their senses before sophisticated analytical techniques became available. Color, taste, and smell were used to detect biological markers [12]. Bacteria are known to have characteristic smells. Bacterial strains have a distinct metabolism, part of which results in the production of bacteria-specific volatile organic compounds (VOCs) [13]–[15]. The metabolic pathways have been described for bacteria in several excellent review articles [14], [15]. However, reviews have not yet focused on pathogens and clinical problems. Detection and identification of VOCs using sophisticated technology may have diagnostic value in medicine [14], [16], [17]. These techniques include gas chromatography and mass spectrometry (GC-MS), selected ion flow tube mass spectrometry (SIFT-MS) [18], ion-molecule reaction mass spectrometry (IMR-MS) [19], [20], and electronic noses (eNoses) [16], [21]. GC-MS is used as a gold standard for separation, detection, and identification of VOCs. SIFT-MS and IMR-MS allow for real-time measurement of some VOCs. eNoses do not identify VOCs but rely on pattern recognition [16]. Volatile compounds can be investigated in vitro (in culture media or directly in patient material) or directly in the exhaled air (in vivo), allowing for noninvasive monitoring. Three goals could be pursued with VOC detection: (1) proof absence of bacterial pathogens (i.e., very high sensitivity and negative predictive value, and therefore no start of antibiotic treatment), (2) identify the presence of a specific strain of bacteria (i.e., very high specificity and positive predictive value, and thus start of appropriate antimicrobial therapy), and (3) separation between phenotypes within bacterial species and therefore prevention of start of antibiotics to which the causative pathogens are not sensitive. However, before VOCs can be tested for these goals in clinical trials, possible diagnostic targets per goal should be known. Therefore, the aim of this review is to provide an overview of volatile organic compounds produced by the six most abundant and pathogenic bacteria in sepsis: Staphylococcus aureus (SA), Streptococcus pneumoniae (SP), Enterococcus faecalis (EF), Pseudomonas aeruginosa (PA), Klebsiella pneumoniae (KP) and Escherichia coli (EC) [22]. RESULTS The MEDLINE search resulted in 837 articles of which 778 were excluded based on title and/or abstract (Figure 1). Fifty-nine articles were read and tested for inclusion criteria. This resulted in the inclusion of twenty-seven articles (Table 1). Ten articles were read based on references, of which four were included, bringing the sum of included articles to thirty–one. [Figure: Inclusion flow diagram.The initial search resulted in 837 hits. Fifty-nine were selected based on title and abstract. Full text was read and references were checked for additional hits. This resulted in ten additional hits. Thirty papers were included based on the full text.] [Table: Literature.] The articles originated from 1977 to 2012, with a rapid increase in the number of publications since 2006. Fifteen articles reported on data collected with GC-MS, seven on data collected with SIFT-MS, three with IMR-MS, and six with other techniques. Seven studies used clinical samples; twenty studies used reference strains. Results on 161 metabolites were obtained, of which a minority was studied in multiple papers. The findings are reported in Tables S1 to S9 in Text S1 and summarized below, per functional group. The most prominent VOCs and their (cross-) association with the six selected gram-positive and gram-negative bacteria are illustrated in Figure 2. [Figure: Interaction plot.The six investigated pathogenic bacteria are plotted on both sides, with gram-positive bacteria on the left and gram-negative on the right. All the metabolites for which convincing evidence on production by at least one of the bacteria was available (as indicated by a green cell in Tables S1 to S9 in Text S1) were included in the figure and connected with a line to all bacteria known to produce a particular metabolite. The stronger the available evidence for the production of a metabolite by one strain of bacteria, the closer the metabolite is situated to the pathogen. Four zones of interest are highlighted. The blue zone in the middle indicates metabolites that are (almost) always produced by all pathogens and are therefore candidate markers with a high sensitivity that might thus qualify for the exclusion of infection (high negative predictive value). The three red zones indicate metabolites that are produced by only or mainly one strain of bacteria; these are possibly volatile